Skip to main content
Terug
BIOA logo

BioAge Labs, Inc.

Datakwaliteit: 100%
BIOA
NASDAQ Healthcare Biotechnology
€ 18,63
▼ € 0,67 (-3,47%)
Marktkapitalisatie: 667,98M
Dagbereik
€ 18,52 € 19,60
52-Weeksbereik
€ 2,88 € 24,00
Volume
459.881
50D / 200D Gem.
€ 20,04 / € 10,02
Vorige Slotkoers
€ 19,30

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E -9,4 0,4
P/B 2,1 2,9
ROE % -95,0 3,8
Net Margin % 3,9
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Belangrijkste Punten

Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -51,89M
PEG of 0,04 suggests growth is underpriced

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-94,98%
ROIC-17,67%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,03
Current Ratio12,86
Interest Coverage-33,04

Waardering

P/E Ratio
-9,39
P/B Ratio2,07
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -71,11M
ROE -94,98% ROA -19,85%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -51,89M
ROIC -17,67% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,03 Current Ratio 12,86
Interest Coverage -33,04 Dividend Yield 0,00%
Valuation
P/E Ratio -9,39 P/B Ratio 2,07
P/S Ratio N/A PEG Ratio 0,04
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 667,98M Enterprise Value 322,33M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue 0,0 0,0 0,0
Net Income -71,11M -63,85M -39,72M
EPS (Diluted) -6,63 -8,55 -5,32
Gross Profit 0,0 0,0 0,0
Operating Income -78,19M -48,40M -39,97M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 358,23M 25,92M 28,43M
Total Liabilities 35,11M 199,32M 140,99M
Shareholders' Equity 323,13M -173,40M -112,56M
Total Debt 8,70M 53,25M 2,47M
Cash & Equivalents 354,35M 21,64M 27,64M
Current Assets 357,10M 25,31M 28,03M
Current Liabilities 27,78M 58,17M 5,86M